This site is optimised for modern browsers. For the best experience, please use Google Chrome, Mozilla Firefox, or Microsoft Edge.

Case study: Will’s story: Valneva’s inactivated COVID-19 Vaccine Trial

For more information about taking part in research please visit the Be Part of Research website.

Find out more

Will’s story: Valneva’s inactivated COVID-19 Vaccine Trial

"The pandemic has affected everyone so negatively and we all just want to get back to regular everyday life now, and I feel a key way that we're going to do this is through the vaccination programmes. So I saw the opportunity to take part in the Valneva study in Bristol and I felt like it would be a really good way to do my bit."

Phase 3 of the Valneva vaccine study opened in Bristol in April 2021.

The vaccine is the only inactivated, adjuvanted COVID-19 vaccine in clinical development in Europe.

Will is one of the volunteers taking part in the study. Watch his story of taking part in research: